ATA905997A - Pharmazeutische zubereitung, die ein mycophenolatsalz enthält - Google Patents

Pharmazeutische zubereitung, die ein mycophenolatsalz enthält

Info

Publication number: ATA905997A
Authority: AT; Austria
Prior art keywords: pharmaceutical preparation; preparation containing; mycophenolate salt; containing mycophenolate; salt
Prior art date: 1996-04-12

Application number

AT0905997A

Other languages

English (en)

Other versions

AT408415B (de

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-04-12

Filing date

1997-04-10

Publication date

2001-04-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309105&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATA905997(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-04-12 Priority claimed from GBGB9607564.3A external-priority patent/GB9607564D0/en

1996-10-24 Priority claimed from GBGB9622028.0A external-priority patent/GB9622028D0/en

1997-04-10 Application filed by Novartis Ag filed Critical Novartis Ag

2001-04-15 Publication of ATA905997A publication Critical patent/ATA905997A/de

2001-11-26 Application granted granted Critical

2001-11-26 Publication of AT408415B publication Critical patent/AT408415B/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Virology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Transplantation (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AT0905997A 1996-04-12 1997-04-10 Pharmazeutische zubereitung, die ein mycophenolatsalz enthält AT408415B (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9607564.3A GB9607564D0 (en)	1996-04-12	1996-04-12	Organic compounds
GBGB9622028.0A GB9622028D0 (en)	1996-10-24	1996-10-24	Organic compounds
PCT/EP1997/001800 WO1997038689A2 (en)	1996-04-12	1997-04-10	Enteric-coated pharmaceutical compositions of mycophenolate

Publications (2)

Publication Number	Publication Date
ATA905997A true ATA905997A (de)	2001-04-15
AT408415B AT408415B (de)	2001-11-26

Family

ID=26309105

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT0905997A AT408415B (de)	1996-04-12	1997-04-10	Pharmazeutische zubereitung, die ein mycophenolatsalz enthält
AT97919330T ATE259228T1 (de)	1996-04-12	1997-04-10	Enterisch überzogene pharmazeutische zusammensetzungen von mycophenolat

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT97919330T ATE259228T1 (de)	1996-04-12	1997-04-10	Enterisch überzogene pharmazeutische zusammensetzungen von mycophenolat

Country Status (34)

Country	Link
US (3)	US6025391A (de)
EP (2)	EP1221316A1 (de)
JP (2)	JP3779732B2 (de)
CN (1)	CN1104238C (de)
AR (2)	AR006583A1 (de)
AT (2)	AT408415B (de)
AU (1)	AU725388B2 (de)
BE (1)	BE1010963A3 (de)
BR (1)	BR9708624A (de)
CO (1)	CO4900024A1 (de)
CY (1)	CY2243B1 (de)
CZ (1)	CZ291811B6 (de)
DE (4)	DE122004000038I2 (de)
DK (1)	DK0892640T3 (de)
ES (2)	ES2216141T3 (de)
FR (1)	FR2747920B1 (de)
GB (1)	GB2326339B (de)
GR (1)	GR1002893B (de)
HK (1)	HK1051484A1 (de)
HU (1)	HU224919B1 (de)
ID (1)	ID18663A (de)
IE (1)	IE970267A1 (de)
IL (1)	IL126431A (de)
IT (1)	IT1297045B1 (de)
LU (1)	LU91094I2 (de)
MY (1)	MY119049A (de)
NL (1)	NL300157I2 (de)
NO (2)	NO322891B1 (de)
NZ (1)	NZ332117A (de)
PT (1)	PT892640E (de)
RU (2)	RU2203659C2 (de)
TR (1)	TR199802056T2 (de)
TW (1)	TW457098B (de)
WO (1)	WO1997038689A2 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000067773A2 (en) *	1999-05-10	2000-11-16	Novartis Ag	Combinations of immunosupressive agents for the treatment or prevention of graft rejections
US20030050692A1 (en) *	2000-12-22	2003-03-13	Avantec Vascular Corporation	Delivery of therapeutic capable agents
GB0124953D0 (en) *	2001-10-17	2001-12-05	Novartis Ag	Organic Compounds
DE60233150D1 (de) *	2001-10-19	2009-09-10	Isotechnika Inc	Neue cyclosporin-analoge mikroemulsionsvorkonzentrate
RU2277090C9 (ru) *	2002-08-29	2006-09-10	Байокон Лимитид	Способ получения натриевой соли микофеноловой кислоты, являющейся иммунодепрессантным средством
GB0301259D0 (en)	2003-01-20	2003-02-19	Novartis Ag	Organic compounds
GB0314553D0 (en) *	2003-06-21	2003-07-30	Weatherford Lamb	Electric submersible pumps
US8993599B2 (en) *	2003-07-18	2015-03-31	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AR045957A1 (es) *	2003-10-03	2005-11-16	Novartis Ag	Composicion farmaceutica y combinacion
PT1729797E (pt) *	2004-03-22	2008-12-17	Solvay Pharm Gmbh	Composições farmacêuticas orais de produtos contendo lipase, em particular de pancreatina, contendo tensioactivos
JP2007532585A (ja)	2004-04-26	2007-11-15	テバジョジセルジャールザ−トケルエンムケドレ−スベニュタ−ルシャシャ−グ	ミコフェノール酸及びそのエステル誘導体の調製方法
MXPA06005660A (es)	2004-04-27	2007-04-10	Teva Gyogyszergyar Zartkoruen	Impureza de micofenolato mofetil.
WO2006012385A2 (en) *	2004-07-20	2006-02-02	Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg	Crystalline mycophenolate sodium
GB0419355D0 (en) *	2004-08-31	2004-09-29	Novartis Ag	Organic compounds
EP1917010A2 (de) *	2005-02-08	2008-05-07	Aspreva Pharmaceuticals SA	Zusammensetzungen und verfahren zur behandlung von gefäss-, autoimmun- und entzündlichen erkrankungen
US20060235009A1 (en)	2005-02-08	2006-10-19	Richard Glickman	Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors
EP1913138B1 (de) *	2005-07-29	2016-08-24	Abbott Laboratories GmbH	Verfahren zur herstellung von pankreatin-pulver mit einem niedrigen virusgehalt
US9198871B2 (en) *	2005-08-15	2015-12-01	Abbott Products Gmbh	Delayed release pancreatin compositions
US11266607B2 (en)	2005-08-15	2022-03-08	AbbVie Pharmaceuticals GmbH	Process for the manufacture and use of pancreatin micropellet cores
CN1985994B (zh) *	2005-12-19	2011-01-12	康泰乐(北京)医药科技发展有限公司	改进的包含霉酚酸盐的包有肠溶衣的药物组合物
JP2009526771A (ja) *	2006-02-13	2009-07-23	ノバルティスアクチエンゲゼルシャフト	高投与量のミコフェノール酸（ｍｐａ）
JP2007230948A (ja) *	2006-03-02	2007-09-13	Univ Meijo	腸溶性化硬カプセル
US10072256B2 (en) *	2006-05-22	2018-09-11	Abbott Products Gmbh	Process for separating and determining the viral load in a pancreatin sample
US20080009050A1 (en) *	2006-06-29	2008-01-10	Zdenek Pokluda	Regulation of acid metabolite production
US20080182998A1 (en) *	2007-01-25	2008-07-31	Apotex Fermentation Inc.	Novel crystalline mycophenolate sodium polymorph and processes to manufacture same
US20080176937A1 (en) *	2007-01-23	2008-07-24	Apotex Fermentation Inc.	Novel crystalline mycophenolate sodium polymorph and processes to manufacture same
WO2008127663A1 (en) *	2007-04-11	2008-10-23	Teva Gyógyszergyár Zártköruen Muködo Részvénytársaság	Method for reducing impurity level in mycophenolic acid fermentation
WO2009022355A1 (en) *	2007-08-13	2009-02-19	Panacea Biotec Limited	Extended release compositions comprising mycophenolate sodium and processes thereof
US20090130063A1 (en) *	2007-11-15	2009-05-21	Solvay Pharmaceuticals Gmbh	Process for separating and determining the viral load in a pancreatin sample
EP2310008A4 (de) *	2008-07-09	2014-03-05	Aspreva Internat Ltd	Ph-spezifische lösungen aus natriummycophenolsäure zur behandlung von augenleiden
US20110086102A1 (en) *	2009-10-13	2011-04-14	Teva Pharmaceutical Industries Ltd.	Delayed release compositions
WO2011046546A1 (en) *	2009-10-13	2011-04-21	Teva Pharmaceutical Industries Ltd.	Delayed release compositions
WO2011051967A2 (en) *	2009-10-23	2011-05-05	Alkem Laboratories Ltd	Pharmaceutical compositions comprising mycophenolate and processes for preparing thereof
CN103880799A (zh) *	2010-11-16	2014-06-25	北京京卫信康医药科技发展有限公司	麦考酚酸钠的新晶型及其制备方法
CN103880800A (zh) *	2010-11-16	2014-06-25	北京京卫信康医药科技发展有限公司	麦考酚酸钠的新晶型及其制备方法
GB201100786D0 (en)	2011-01-18	2011-03-02	Ems Sa	Pharmaceutical compositions of immunosuppressants
WO2013041205A1 (de)	2011-09-19	2013-03-28	Pyxirion Pharma Gmbh	Neue therapeutische konzepte zur behandlung von gefässerkrankungen
SG10201707543PA (en)	2013-03-14	2017-11-29	Alkermes Pharma Ireland Ltd	Prodrugs of fumarates and their use in treating various deseases
US8669281B1 (en)	2013-03-14	2014-03-11	Alkermes Pharma Ireland Limited	Prodrugs of fumarates and their use in treating various diseases
WO2014167442A1 (en)	2013-03-26	2014-10-16	Wockhardt Limited	Pharmaceutical compositions comprising mycophenolic acid or salts thereof
KR102351422B1 (ko)	2014-01-06	2022-01-13	실드 티엑스 (유케이) 리미티드	철 트리말톨의 복용량 양생법
ES2753361T3 (es)	2014-02-24	2020-04-08	Alkermes Pharma Ireland Ltd	Sulfonamida y profármacos de fumaratos de sulfinamida y su uso en el tratamiento de diversas enfermedades
GB201418710D0 (en)	2014-10-21	2014-12-03	Iron Therapeutics Holdings Ag	Dosage regimen
US10213411B2 (en)	2015-08-27	2019-02-26	Vijaykumar Rajasekhar	Use of prodrugs of fumarates in treating heart failure diseases
US10463642B2 (en)	2016-02-01	2019-11-05	Vijaykumar Rajasekhar	Methods of treating heart failure diseases using prodrugs of methyl hydrogen fumarate
MX2019010829A (es) *	2017-03-13	2020-02-05	Okava Pharmaceuticals Inc	Metodos y composiciones para suministrar agentes activos de acido micofenolico a mamiferos no humanos.
CN117177749A (zh)	2021-03-03	2023-12-05	萨那生物科技公司	与心肌细胞疗法一起使用的免疫抑制疗法以及相关的方法和组合物
CN114028334B (zh) *	2021-12-10	2023-08-29	卓和药业集团股份有限公司	一种肺部给药的免疫抑制剂的制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1157100A (en) *	1966-09-27	1969-07-02	Ici Ltd	Pharmaceutical Compositions
GB1157099A (en) *	1966-09-27	1969-07-02	Ici Ltd	Fermentation Process
GB1173942A (en) *	1967-06-06	1969-12-10	Bellon Labor Sa Roger	New 2,3-Dihydro-1,4-Benzoxazines
GB1158387A (en) *	1967-06-13	1969-07-16	Ici Ltd	Procedure for Isolation of Mycophenolic Acid
GB1203328A (en) *	1968-06-04	1970-08-26	Ici Ltd	Pharmaceutical compositions
GB1261060A (en) *	1969-09-09	1972-01-19	Ici Ltd	Phthalen-1-one derivatives
US3705946A (en) *	1971-05-25	1972-12-12	Lilly Co Eli	Method of treating hyperuricemia
JPS5542995B2 (de) *	1972-02-24	1980-11-04
US3825571A (en) *	1971-07-31	1974-07-23	Chugai Pharmaceutical Co Ltd	Mycophenolic acid derivatives
US3868454A (en) *	1972-08-14	1975-02-25	Lilly Co Eli	Psoriasis treatment with mycophenolic acid derivatives
US3777020A (en) *	1972-08-14	1973-12-04	Lilly Co Eli	Psoriasis treatment with mycophenolic acid
US4005108A (en) *	1973-04-03	1977-01-25	Research Corporation	Novel anti-leukemic diterpenoid triepoxides
US3880995A (en) *	1973-05-14	1975-04-29	Lilly Co Eli	Treatment of arthritis with mycophenolic acid and derivatives
US3903071A (en) *	1973-05-22	1975-09-02	Lilly Co Eli	Mycophenolic acid derivatives
JPS517116A (en) *	1974-06-11	1976-01-21	Shinetsu Chemical Co	Choyoseihifukuyakuzaino seizohoho
US4234684A (en) *	1979-12-11	1980-11-18	Eli Lilly And Company	Method of preparing mycophenolic acid glucoside
IT1150194B (it) *	1982-02-23	1986-12-10	Chiesi Farma Spa	Formulazioni farmaceutiche ad attivita'antiinfiammatoria, analgesica,antipiretica e gastroprotettiva
US4680299A (en) *	1984-04-30	1987-07-14	E.I. Du Pont De Nemours And Company	2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
US4686234A (en) *	1985-11-27	1987-08-11	Syntex (U.S.A) Inc.	Mycophenolic acid derivatives in the treatment of inflammatory diseases, in particular rheumatoid arthritis
US4725622A (en) *	1986-01-23	1988-02-16	Syntex (U.S.A.) Inc.	Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4959387A (en) *	1986-01-23	1990-09-25	Syntex (U.S.A.) Inc.	Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4727069A (en) *	1987-01-30	1988-02-23	Syntex (U.S.A.) Inc.	Heterocyclic aminoalkyl esters of mycophenolic acid, derivatives thereof and pharmaceutical compositions
US4753935A (en) *	1987-01-30	1988-06-28	Syntex (U.S.A.) Inc.	Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
US4847381A (en) *	1987-08-31	1989-07-11	American Cyanamid Company	2-Phenyl-4-quinoline carboxylic acids
US5135934A (en) *	1990-07-06	1992-08-04	Du Pont Merck Pharmaceutical Company	3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents
US5372298A (en) *	1992-01-07	1994-12-13	The Regents Of The University Of California	Transient liquid phase ceramic bonding
US5516781A (en) *	1992-01-09	1996-05-14	American Home Products Corporation	Method of treating restenosis with rapamycin
CA2086642C (en) *	1992-01-09	2004-06-15	Randall E. Morris	Method of treating hyperproliferative vascular disease
US5283257A (en) *	1992-07-10	1994-02-01	The Board Of Trustees Of The Leland Stanford Junior University	Method of treating hyperproliferative vascular disease
WO1994026265A1 (en) *	1993-05-06	1994-11-24	Pharmagenesis, Inc.	16-hydroxytriptolide composition and method for immunotherapy
US5455045A (en) *	1993-05-13	1995-10-03	Syntex (U.S.A.) Inc.	High dose formulations
US5428040A (en) *	1993-08-31	1995-06-27	The Du Pont Merck Pharmaceutical Company	Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
EP0721335B1 (de) *	1993-10-01	2005-08-31	Roche Palo Alto LLC	Hochdosierte oral anzuwendende suspensionen enthaltendmycophenolat mofetil
WO1995013082A1 (en) *	1993-11-08	1995-05-18	Pharmagenesis, Inc.	Immunotherapy composition and method
WO1995014023A1 (en) *	1993-11-19	1995-05-26	Abbott Laboratories	Semisynthetic analogs of rapamycin (macrolides) being immunomodulators

1997
- 1997-04-01 ID IDP971201A patent/ID18663A/id unknown
- 1997-04-08 BE BE9700319A patent/BE1010963A3/fr not_active IP Right Cessation
- 1997-04-10 NZ NZ332117A patent/NZ332117A/xx not_active IP Right Cessation
- 1997-04-10 CZ CZ19983267A patent/CZ291811B6/cs not_active IP Right Cessation
- 1997-04-10 AU AU23843/97A patent/AU725388B2/en not_active Expired
- 1997-04-10 DK DK97919330T patent/DK0892640T3/da active
- 1997-04-10 DE DE1997627559 patent/DE122004000038I2/de active Active
- 1997-04-10 TW TW086104578A patent/TW457098B/zh not_active IP Right Cessation
- 1997-04-10 CO CO97018556A patent/CO4900024A1/es unknown
- 1997-04-10 US US09/077,398 patent/US6025391A/en not_active Expired - Lifetime
- 1997-04-10 MY MYPI97001573A patent/MY119049A/en unknown
- 1997-04-10 DE DE69727559T patent/DE69727559T2/de not_active Expired - Lifetime
- 1997-04-10 IL IL12643197A patent/IL126431A/xx active Protection Beyond IP Right Term
- 1997-04-10 GB GB9821304A patent/GB2326339B/en not_active Expired - Lifetime
- 1997-04-10 JP JP53672597A patent/JP3779732B2/ja not_active Expired - Lifetime
- 1997-04-10 AT AT0905997A patent/AT408415B/de not_active IP Right Cessation
- 1997-04-10 WO PCT/EP1997/001800 patent/WO1997038689A2/en not_active Ceased
- 1997-04-10 BR BR9708624A patent/BR9708624A/pt not_active IP Right Cessation
- 1997-04-10 AT AT97919330T patent/ATE259228T1/de active
- 1997-04-10 GR GR970100135A patent/GR1002893B/el not_active IP Right Cessation
- 1997-04-10 AR ARP970101419A patent/AR006583A1/es active IP Right Grant
- 1997-04-10 IE IE970267A patent/IE970267A1/en not_active IP Right Cessation
- 1997-04-10 DE DE19781690T patent/DE19781690D2/de not_active Expired - Lifetime
- 1997-04-10 RU RU98120360/14A patent/RU2203659C2/ru active
- 1997-04-10 CN CN97193760A patent/CN1104238C/zh not_active Expired - Lifetime
- 1997-04-10 ES ES97919330T patent/ES2216141T3/es not_active Expired - Lifetime
- 1997-04-10 RU RU0098120360A patent/RU2615397C2/ru active
- 1997-04-10 EP EP02001803A patent/EP1221316A1/de not_active Withdrawn
- 1997-04-10 HU HU9903373A patent/HU224919B1/hu active Protection Beyond IP Right Term
- 1997-04-10 PT PT97919330T patent/PT892640E/pt unknown
- 1997-04-10 ES ES009850018A patent/ES2178510B1/es not_active Expired - Fee Related
- 1997-04-10 TR TR1998/02056T patent/TR199802056T2/xx unknown
- 1997-04-10 DE DE200412000038 patent/DE122004000038I1/de active Pending
- 1997-04-10 EP EP97919330A patent/EP0892640B1/de not_active Expired - Lifetime
- 1997-04-11 FR FR9704496A patent/FR2747920B1/fr not_active Expired - Lifetime
- 1997-04-11 IT IT97RM000207A patent/IT1297045B1/it active IP Right Grant
1998
- 1998-10-09 NO NO19984728A patent/NO322891B1/no not_active IP Right Cessation
1999
- 1999-04-13 HK HK03100274.4A patent/HK1051484A1/en unknown
- 1999-12-22 US US09/469,536 patent/US6172107B1/en not_active Expired - Lifetime
2000
- 2000-10-23 US US09/694,209 patent/US6306900B1/en not_active Expired - Lifetime
2001
- 2001-10-12 CY CY0100032A patent/CY2243B1/xx unknown
2004
- 2004-08-05 NL NL300157C patent/NL300157I2/nl unknown
- 2004-08-11 LU LU91094C patent/LU91094I2/fr unknown
2005
- 2005-11-09 JP JP2005325141A patent/JP2006063086A/ja active Pending
2007
- 2007-03-01 AR ARP070100839A patent/AR059693A2/es not_active Application Discontinuation
- 2007-03-26 NO NO2007004C patent/NO2007004I2/no unknown

Also Published As

Publication number	Publication date
EP0892640B1 (de)	2004-02-11
US6025391A (en)	2000-02-15
ES2178510B1 (es)	2004-08-16
IT1297045B1 (it)	1999-08-03
FR2747920B1 (fr)	1999-12-31
DE19781690D2 (de)	1999-04-08
WO1997038689A3 (en)	1997-12-04
IL126431A0 (en)	1999-08-17
HUP9903373A2 (hu)	2001-04-28
EP0892640A2 (de)	1999-01-27
NO2007004I2 (no)	2009-10-19
MY119049A (en)	2005-03-31
CN1104238C (zh)	2003-04-02
HU224919B1 (en)	2006-04-28
TW457098B (en)	2001-10-01
FR2747920A1 (fr)	1997-10-31
PT892640E (pt)	2004-06-30
GB2326339B (en)	2000-04-19
HK1016490A1 (en)	1999-11-05
CN1215991A (zh)	1999-05-05
ID18663A (id)	1998-04-30
NZ332117A (en)	2000-04-28
JP2006063086A (ja)	2006-03-09
GB9821304D0 (en)	1998-11-25
NO984728L (no)	1998-12-02
AR006583A1 (es)	1999-09-08
AU725388B2 (en)	2000-10-12
NO2007004I1 (no)	2007-04-16
CZ291811B6 (cs)	2003-06-18
IE970267A1 (en)	1997-10-22
CY2243B1 (en)	2003-07-04
ITRM970207A1 (it)	1998-10-11
AU2384397A (en)	1997-11-07
US6172107B1 (en)	2001-01-09
NL300157I1 (nl)	2004-10-01
DK0892640T3 (da)	2004-05-10
NL300157I2 (nl)	2004-12-01
GR1002893B (el)	1998-04-10
DE122004000038I1 (de)	2006-01-26
DE69727559T2 (de)	2004-12-16
JP2000503665A (ja)	2000-03-28
US6306900B1 (en)	2001-10-23
CO4900024A1 (es)	2000-03-27
ES2216141T3 (es)	2004-10-16
LU91094I2 (fr)	2004-10-11
CZ326798A3 (cs)	1999-01-13
BE1010963A3 (fr)	1999-03-02
ES2178510A1 (es)	2002-12-16
AR059693A2 (es)	2008-04-23
NO984728D0 (no)	1998-10-09
TR199802056T2 (xx)	1999-02-22
JP3779732B2 (ja)	2006-05-31
HUP9903373A3 (en)	2001-05-28
RU2615397C2 (ru)	2017-04-04
WO1997038689A2 (en)	1997-10-23
IL126431A (en)	2005-03-20
NO322891B1 (no)	2006-12-18
AT408415B (de)	2001-11-26
RU2203659C2 (ru)	2003-05-10
HK1051484A1 (en)	2003-08-08
GB2326339A (en)	1998-12-23
BR9708624A (pt)	1999-08-03
DE122004000038I2 (de)	2006-04-27
DE69727559D1 (de)	2004-03-18
ATE259228T1 (de)	2004-02-15
EP1221316A1 (de)	2002-07-10

Publication	Publication Date	Title
ATA905997A (de)	2001-04-15	Pharmazeutische zubereitung, die ein mycophenolatsalz enthält
DE69018647D1 (de)	1995-05-18	Arzneimittel.
DE69738460D1 (de)	2008-02-21	Pharmazeutische Zusammensetzung mit verzögerter Freisetzung, die wasserunlösliche Komplexverbindungen enthalten
FI903382A0 (fi)	1990-07-04	Topiskt anbringbara farmaceutiska preparat.
DE69101931D1 (de)	1994-06-16	Pharmazeutische Zusammensetzung.
DE69802268D1 (de)	2001-12-06	Medizinische präparation,die ein lipophiles edelgas enthält
ATE71837T1 (de)	1992-02-15	Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
DE69001730D1 (de)	1993-07-01	Pastenfoermige, waesserige pharmazeutische zusammensetzungen.
FI915826L (fi)	1992-03-31	Farmaceutiska aemnen.
FI973243L (fi)	1997-08-06	Uusi farmaseuttinen yhdistelmä
HU9603495D0 (en)	1997-02-28	1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, as pharmaceutical agents
NO20004345D0 (no)	2000-09-01	Farmasøytisk sammensetning
ATE238776T1 (de)	2003-05-15	Geschmacksmaskierte pharmazeutische dosisform mit schneller freisetzung
ATE222105T1 (de)	2002-08-15	Arzneimittel mit verzögerter freisetzung, das ein dibenzothiazepinderivat enthält
DE69006094D1 (de)	1994-03-03	Pharmazeutische Zusammensetzungen.
ATE432707T1 (de)	2009-06-15	Pharmazeutische zubereitung
TR199802624A3 (tr)	1999-10-21	Yeni farmasötik.
BR9610214A (pt)	1999-06-15	Compostos farmacéuticos
ZA961884B (en)	1997-09-09	Novel naphthyl pharmaceutical compounds.
FI973229A0 (fi)	1997-08-05	Uusi farmaseuttinen koostumus
FI973280A0 (fi)	1997-08-08	Farmaseuttinen koostumus
NO973611D0 (no)	1997-08-05	Nytt farmasöytisk preparat
FI951155A7 (fi)	1995-09-15	Farmaseuttinen valmiste
TR199601018A1 (tr)	1997-07-21	Farmasötik bilesikler.
DE58905160D1 (de)	1993-09-09	Pharmazeutische zubereitung.

Legal Events

Date	Code	Title	Description
2005-07-15	SZA	Application filed for a certificate of protection	Free format text: SZ 18/2004, 20040818 Spc suppl protection certif: SZ 18/2004 Filing date: 20040818
2007-06-15	EZF	Grant of a certificate of protection	Free format text: SZ 18/2004, 20040818, EXPIRES:20171024 Spc suppl protection certif: SZ 18/2004 Filing date: 20040818 Expiry date: 20171024
2017-05-15	MK07	Expiry	Effective date: 20170410
2017-12-15	SPCX	Expiry of an spc	Free format text: PRODUCT NAME: MYCOPHENOLATSALZ; NAT. REGISTRATION NO/DATE: 1-25367, 1-25368 20040428; FIRST REGISTRATION: CH 5611501, 5611502 20021024 Spc suppl protection certif: 18/2004 Filing date: 20040818 Expiry date: 20170410 Extension date: 20171024 Effective date: 20171024